<p>Comparison of TGF-β (A), IL-6 (B), IL-23 (C) cytokines concentrations between HC, RRMS patients in relapse and remission phase, SPMS and PPMS patients. Pearson’s correlation and regression tests between TGF-β (D), IL-6 (E), IL-23 (F) and Tc17 cells in MS patients. One-way ANOVA was used to test for differences between the groups. Subsequent multiple comparison pairwise test was Bonferroni. <i>* P-value <0</i>.<i>05</i>.</p
In vitro production of tumor necrosis factor-alpha (TNF-alpha), interleukin-2 (IL-2), IL-4, IL-6, IL...
BackgroundMultiple sclerosis (MS) is a chronic, progressive autoimmune disease of the central nervou...
Levels of tumor necrosis factor (TNF)-alpha, granulocyte macrophage-colony stimulating factor (GM-CS...
Objectives A clinical and laboratory study was performed to evaluate the plasmatic profile of cytoki...
Objectives A clinical and laboratory study was performed to evaluate the plasmatic profile of cytoki...
<div><p>Multiple sclerosis (MS) is an autoimmune disease with the impaired balance of CD4<sup>+</sup...
<p>The percentage of IFN-γ (Tc1) (A), IL-17 (Tc17) (B), IL-21 (Tc21) (C) and TNF-α (D) producing CD8...
Recent evidence points to a pathogenic role for CD8+ cytotoxic T (Tc) cells in Multiple sclerosis (M...
BACKGROUND: Concomitant signals from IL-6 and TGF-β have a central role in the Th17 cells developmen...
<p>The levels of plasma and CSF IL-21 in individual subjects were tested by ELISA. (A) The levels of...
We performed a longitudinal analysis of serum IL2, IL6 and TNF alpha concentrations in 40 relapsing ...
Reliable, and easy to measure, immunological markers able to denote disease characteristics in multi...
Multiple sclerosis (MS) is an inflammatory, demyelinating disease of the central nervous system. Eff...
In vitro production of tumor necrosis factor-alpha (TNF-alpha), interleukin-2 (IL-2), IL-4, IL-6, IL...
In vitro production of tumor necrosis factor-alpha (TNF-alpha), interleukin-2 (IL-2), IL-4, IL-6, IL...
In vitro production of tumor necrosis factor-alpha (TNF-alpha), interleukin-2 (IL-2), IL-4, IL-6, IL...
BackgroundMultiple sclerosis (MS) is a chronic, progressive autoimmune disease of the central nervou...
Levels of tumor necrosis factor (TNF)-alpha, granulocyte macrophage-colony stimulating factor (GM-CS...
Objectives A clinical and laboratory study was performed to evaluate the plasmatic profile of cytoki...
Objectives A clinical and laboratory study was performed to evaluate the plasmatic profile of cytoki...
<div><p>Multiple sclerosis (MS) is an autoimmune disease with the impaired balance of CD4<sup>+</sup...
<p>The percentage of IFN-γ (Tc1) (A), IL-17 (Tc17) (B), IL-21 (Tc21) (C) and TNF-α (D) producing CD8...
Recent evidence points to a pathogenic role for CD8+ cytotoxic T (Tc) cells in Multiple sclerosis (M...
BACKGROUND: Concomitant signals from IL-6 and TGF-β have a central role in the Th17 cells developmen...
<p>The levels of plasma and CSF IL-21 in individual subjects were tested by ELISA. (A) The levels of...
We performed a longitudinal analysis of serum IL2, IL6 and TNF alpha concentrations in 40 relapsing ...
Reliable, and easy to measure, immunological markers able to denote disease characteristics in multi...
Multiple sclerosis (MS) is an inflammatory, demyelinating disease of the central nervous system. Eff...
In vitro production of tumor necrosis factor-alpha (TNF-alpha), interleukin-2 (IL-2), IL-4, IL-6, IL...
In vitro production of tumor necrosis factor-alpha (TNF-alpha), interleukin-2 (IL-2), IL-4, IL-6, IL...
In vitro production of tumor necrosis factor-alpha (TNF-alpha), interleukin-2 (IL-2), IL-4, IL-6, IL...
BackgroundMultiple sclerosis (MS) is a chronic, progressive autoimmune disease of the central nervou...
Levels of tumor necrosis factor (TNF)-alpha, granulocyte macrophage-colony stimulating factor (GM-CS...